Multidisciplinary Management of Drug Shortages and Associated Ethical Dilemmas
Back to course
Pdf Summary
Asset Subtitle
Pharmacology, Crisis Management, 2024, 00:07:51
Asset Caption
"This article was first published in the Spring 2024 issue of Critical Connections.

Drug shortages have posed significant patient safety issues in the past, including during the COVID-19 pandemic as shortages affected immunomodulators (e.g., tocilizumab), antivirals (e.g., remdesivir), sedatives, and opioid analgesics. Creating a multidisciplinary drug shortages committee to monitor and make rapid evidence-based decisions during drug shortages is essential for every hospital and healthcare system.

Critical Connections, the critical care industry’s only newsmagazine, provides information on cutting-edge topics in critical care useful to the entire multiprofessional team."
Meta Tag
Content Type Article
Knowledge Area Pharmacology
Knowledge Area Crisis Management
Membership Level Associate
Membership Level Professional
Membership Level Select
Tag Pharmacology
Tag Resource Allocation
Year 2024
Keywords
multidisciplinary committees
drug shortages
Article
healthcare systems
clear communication
stakeholders
management strategies
Pharmacology
COVID-19 pandemic
Crisis Management
scarce resource allocation committees
information technology specialists
ethical considerations
Resource Allocation
2024
Associate
Professional
Select